Cargando…
Pharmacokinetics and Pharmacodynamics of Fosfomycin and Its Activity against Extended-Spectrum-β-Lactamase-, Plasmid-Mediated AmpC-, and Carbapenemase-Producing Escherichia coli in a Murine Urinary Tract Infection Model
Fosfomycin has become an attractive treatment alternative for urinary tract infections (UTIs) due to increasing multidrug resistance (MDR) in Escherichia coli. In this study, we evaluated the pharmacokinetic (PK) and pharmacodynamic (PD) indices of fosfomycin and its in vivo activity in an experimen...
Autores principales: | Zykov, Ilya Nikolaevich, Samuelsen, Ørjan, Jakobsen, Lotte, Småbrekke, Lars, Andersson, Dan I., Sundsfjord, Arnfinn, Frimodt-Møller, Niels |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5971609/ https://www.ncbi.nlm.nih.gov/pubmed/29581117 http://dx.doi.org/10.1128/AAC.02560-17 |
Ejemplares similares
-
Detection of plasmid-mediated AmpC β-lactamase in Escherichia coli
por: LIU, XIANGQUN, et al.
Publicado: (2016) -
The Novel CarbaLux Test for Carbapenemases and Carbapenem Deactivating AmpC Beta-Lactamases
por: Pfaendler, Hans Rudolf, et al.
Publicado: (2020) -
Determination of Extended-Spectrum β-Lactamases and AmpC Production in Uropathogenic Isolates of Escherichia coli and Susceptibility to Fosfomycin
por: Gupta, Varsha, et al.
Publicado: (2013) -
Prevalence of extended-spectrum β-lactamases, AmpC, and carbapenemases in Proteus mirabilis clinical isolates
por: Shaaban, Mona, et al.
Publicado: (2022) -
Role of AmpR in the High Expression of the Plasmid-Encoded AmpC β-Lactamase CFE-1
por: Nakano, Ryuichi, et al.
Publicado: (2017)